23andMe Holding Co (ME)
0.5023
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.5028
0.00 (0.00%)
After-Hours: 20:00
23andMe Cash from Operations (TTM): -183.50M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -183.50M |
September 30, 2023 | -145.89M |
June 30, 2023 | -161.70M |
March 31, 2023 | -165.39M |
December 31, 2022 | -155.63M |
September 30, 2022 | -205.78M |
Date | Value |
---|---|
June 30, 2022 | -195.34M |
March 31, 2022 | -166.83M |
December 31, 2021 | -171.89M |
September 30, 2021 | -118.86M |
June 30, 2021 | -85.88M |
March 31, 2021 | -74.25M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-205.78M
Minimum
Sep 2022
-74.25M
Maximum
Mar 2021
-152.58M
Average
-163.55M
Median
Cash from Operations (TTM) Benchmarks
RadNet Inc | 220.86M |
DermTech Inc | -76.98M |
iSpecimen Inc | -5.808M |
Sera Prognostics Inc | -27.19M |
Invitae Corp | -238.22M |